The effects of dry needling on the autonomic nervous system function in healthy subjects: a randomized single blind clinical trial

Completed

• Conditions: Autonomic nervous system; Physical Medicine / Rehabilitation - Physiotherapy; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12616000881437
• Lead Sponsor: Alcala Henares University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-07-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Subjects need to be:
- Healthy
- Between 18 and 65 .
Subjects need to have:
- Latent myofascial trigger point at adductor pollicis muscle in left hand
- No pain

Exclusion Criteria

Participants will be excluded from the study if they have a history of acute illness, malignancy, pregnancy, muscle disease, cognitive dysfunction, fibromyalgia, neurological disorders, metabolic disorders, fear of needles, and previous dry needling intervention in the last 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of heart rate, with a multiparametric biofeedback: the NeXus 10 MK-II (Mind Media BV; Herten, the Netherlands). [Baseline, continuous monitoring from needle application to needle removal, and 10 minutes after finishing the dry needling]

Secondary Outcome Measures

Name	Time	Method
Measurement of breathing rate with a multiparametric biofeedback: the NeXus 10 MK-II (Mind Media BV; Herten, the Netherlands). [Baseline, continuous monitoring from needle application to needle removal, and 10 minutes after finishing the dry needling];Measurement of skin conductance, with a multiparametric biofeedback: the NeXus 10 MK-II (Mind Media BV; Herten, the Netherlands). [Baseline, continuous monitoring from needle application to needle removal, and 10 minutes after finishing the dry needling];Measurement of skin temperature, with a multiparametric biofeedback: the NeXus 10 MK-II (Mind Media BV; Herten, the Netherlands). [Baseline, continuous monitoring from needle application to needle removal, and 10 minutes after finishing the dry needling];Measurement of salivary cortisol, with the Salivette (Registered Trademark) Cortisol. [Baseline, and 3 minutes after finishing the dry needling.]